We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Lilly announces details of presentations at the 2024 American Society of Hematology (ASH) Annual Meeting PR Newswire INDIANAPOLIS, Nov. 5, 2024 INDIANAPOLIS, Nov. 5, 2024 /PRNewswire/ -- Eli...
Lilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and Additional Results from Its Breast Cancer Portfolio at the San Antonio Breast Cancer Symposium PR...
Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products PR Newswire INDIANAPOLIS, Oct. 30, 2024 Revenue in Q3 2024 increased 20%, driven by...
U.S. index futures rose slightly in Wednesday’s pre-market as traders assessed Alphabet (NASDAQ:GOOGL)’s strong quarterly results released post-close, while AMD (NASDAQ:AMD) shares dropped...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions